Vaccines Market In 2015 To Reach US$5.6 Billion

GLOBAL - The global veterinary vaccines market will reach US$5.6 billion by 2015, according to a new market report.
calendar icon 24 February 2011
clock icon 3 minute read

Given the frequent outbreaks of animal diseases such as bird flu, avian influenza, anthrax and other viral and bacterial infections, animal healthcare has gained tremendous significance across the globe, over the years, according to a press release in SFGate from Global Industry Analysts, Inc. Livestock owners have turned to animal healthcare products for safeguarding health of their cattle, and poultry birds and for enhancing productivity. Pet owners too have embraced animal healthcare products guided by the desire to keep their pets healthy. Against this backdrop veterinary vaccines have gained strong foothold in the global animal care sector, serving the needs of livestock, poultry and pet care markets. Capable of stimulating the body to create antibodies or cellular immune responses to kill or neutralize the disease-causing organism without any side effects, veterinary vaccines have become a perfect defense mechanism for preventing several animal diseases.

The global veterinary vaccines market waned in 2008 and 2009, as a result of the global meltdown. The market, nevertheless, recovered in 2010 and is expected to post substantial growth in ensuing years. Growing demand for the vaccines from Asia, Latin America and Eastern European countries and increased vulnerability of animals to the diseases is steering the demand for veterinary vaccines. Rapidly changing patterns of the diseases among the animals and increased development of resistance to the currently used antimicrobials is compelling the manufacturers to invest heavily in new product developments. Adoption of novel animal husbandry techniques and different farming conditions are attributed as the major factors for emergence of newer diseases. Growing awareness on animal health and benefits of early detection and preventive medicines will drive the demand for veterinary vaccines over the next few years. Technology innovations, in particular DNA-related vaccines, and introduction of new products that are capable of ensuring greater production and immune responses than traditional vaccines also augurs well for the future of veterinary vaccines market.

As stated by the new market research report on veterinary vaccines, the livestock vaccines market represents the largest product segment. Growth in the Livestock Vaccines market is essentially driven by Porcine Vaccines market, which not only accounts for a majority share of the total market but is also one of the fastest growing segments.

Key players in the marketplace include Bayer HealthCare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd, Lohmann Animal Health, Merck & Co. Inc., Intervet/Schering-Plough Animal Health, Merial Ltd., Pfizer Inc., Embrex Inc., Fort Dodge Animal Health, Protein Sciences Corporation, Virbac Corporation, among others.

The research report titled Veterinary Vaccines: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of the veterinary vaccines market, current market trends, key growth drivers, recent product introductions, recent industry activity and profiles of major/niche global as well as regional market participants. This study provides market estimates and projections in terms of annual revenues (in US$ million) for regional markets including US, Europe and 'rest of the world' markets. Product segments covered in the report include companion animals' vaccines (canine vaccines and feline vaccines) and livestock vaccines (porcine vaccines, bovine vaccines, poultry vaccines, ovine vaccines and equine vaccines among other animal vaccines).

Further Reading

- You can view the full report (fee payable) by clicking here.
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.